However, as opposed to previous reports, we were able to demonstrate for the first time that infiltration specifically of the epithelial-neoplastic compartment by CD8-positive cytotoxic T lymphocytes is the key marker for tumor sensitivity to primary (chemo-) radiotherapy in OPSCC. This evidence concerns the gene CD8A and neoplasm.